a comprehensive review, page-8

Hmm nice review. One question that comes to mind from reading that though - if there's so much competition wouldn't the value of the company in the long term depend a lot on its operating efficiency? The way I see it is that it looks like a Coles/Woolworths fight for the pharmacy dollar now. If that international pharma which has 1/3 of the market can manufacture its drugs at a lower cost than Sigma it could theoretically employ the same strategy woolworths did to coles. IE: sacrifice profits for market share and end up being a consistently lower cost supplier to the industry. Long term surely that will put pressure on Sigma maintaining its market share. Just my theory of course, pure conjecture, and assumes the international pharma is a lower cost producer than sigma (I don't know if this is true, don't know where to find the information)